{"id":8011,"date":"2018-04-09T17:35:35","date_gmt":"2018-04-09T21:35:35","guid":{"rendered":"https:\/\/digital.hbs.edu\/platform-digit\/submission\/flatiron-health-solving-cancer-through-data-analytics\/"},"modified":"2018-04-09T17:39:31","modified_gmt":"2018-04-09T21:39:31","slug":"flatiron-health-solving-cancer-through-data-analytics","status":"publish","type":"hck-submission","link":"https:\/\/d3.harvard.edu\/platform-digit\/submission\/flatiron-health-solving-cancer-through-data-analytics\/","title":{"rendered":"Flatiron Health \u2013 solving cancer through data analytics"},"content":{"rendered":"

Flatiron Health is using data and analytics to tackle cancer, which it believes cannot be \u201csolved\u201d by just the healthcare community \u2013 it needs the technology industry as well. Therefore, since Flatiron started in 2012, it has grown to nearly 500 individuals with backgrounds in healthcare and technology: tech firms like Google and Amazon, cancer centers ranging from Memorial Sloan-Kettering to private practices in rural America, academia, biopharma companies, nonprofits, and government agencies. [1]<\/a><\/p>\n

Flatiron makes software to improve the workflow in cancer clinics and aggregates anonymized data from that software to share with pharmaceutical companies and research institutes.[2]<\/a>\u00a0 This software is its market leading, oncology-specific electronic health record platform.\u00a0 Flatiron\u2019s goal is to accelerate cancer research and improve patient care by enabling cancer researchers and care providers to leverage this platform and learn from the experience of each patient to further the development of new treatments.[3]<\/a><\/p>\n

How does the data create value for Flatiron? \u00a0How is it different from its competitors?<\/strong><\/p>\n

Flatiron\u2019s key asset is its abil\"\"<\/a>ity to source data from a multitude of sources and analyze it to make meaningful recommendations. The Flatiron platform captures and normalizes both structured and unstructured oncology data from sources such as laboratories, research repositories, payer networks etc.\u00a0 Then, its analytics engine pulls out relevant insights from the data, which, when combined with electronic medical records (EMR) data, generate real-world evidence.[4]<\/a>\u00a0 Why is this valuable?\u00a0 Because it can help find a cure for cancer and save billions of dollars.<\/p>\n

Research suggests that only 3-5% of clinical trial enrollment yields desired results and developing a blockbuster drug takes 10+ years and $2.5-3 billion in investment.[5]<\/a> The Flatiron platform can help identify the right patient cohorts for almost 15 types of cancer conditions for clinical trials, thereby optimizing clinical trial enrollment. \u00a0Moreover, Flatiron\u2019s data is valuable because this real-world evidence can be used to evaluate drug efficacy and utility, a critical requirement by the FDA (regulator).\u00a0 Additionally, this data can be used for clinical research, to fast track clinical trials, and to price the drug effectively (by insurers).\u00a0 In summary, a pharmaceutical company will save money on clinical trials, make quicker decisions, and have a faster time-to-market by using Flatiron Health.\u00a0 This is why Roche, a pharmaceutical giant for which Oncology represents 60% of its revenue, bought Flatiron Health for $1.9B a month ago.[6]<\/a><\/p>\n

Further, Flatiron gets data from 265 community oncology practices across the US, has a partnership with the National Cancer Institute, and touches over 2 million cancer patients annually (that\u2019s 1 in 8 people diagnosed with cancer in the US).[7]<\/a>\u00a0 Access to such a powerful dataset makes Flatiron unique.\u00a0 However, Flatiron\u2019s real differentiator is that its datasets are curated to separate statistical noise from actionable information.[8]<\/a>\u00a0 It does this through a team of more than 500 nurses, certified tumor registrars, and clinical research associates who go through unstructured documents such as doctors\u2019 notes, radiology reports, and lab results and enter them into a proprietary portal as structured fields, so that researchers can perform queries and analysis on large cohorts.[9]<\/a><\/p>\n

How does Flatiron capture value from data and analytics? How is it different from its competitors?<\/strong><\/p>\n

Flatiron\u2019s organized and accurate datasets, combined with its data analytics infrastructure, is valuable for oncology R&D efforts across the entire life sciences industry.\u00a0 This is proven by the fact that 14 of the top 15 life science companies in Oncology use Flatiron to advance their research.[10]<\/a>\u00a0 This forms the core of how Flatiron captures value, and Roche realizes this because even after the acquisition, it intends to maintain Flatiron as an independent subsidiary so that Flatiron can provide its services across pharmaceutical companies.[11]<\/a><\/p>\n

The biggest testament to Flatiron\u2019s ability to create and capture value is how it has been acquired for ~$2 billion after 5 years of starting.\u00a0 None of its competitors have such a wide client base or achieved such liquidation.<\/p>\n

What challenges has Flatiron overcome? \u00a0What challenges and opportunities lie in its future?<\/strong><\/p>\n

Sourcing clinical data from a variety of sources, then curating datasets to make them amenable to analysis, and finally using the resulting insights to inform clinical trial enrollment, patient care, and drug efficacy have been hurdles that Flatiron has overcome.\u00a0 Doing this at a mass scale is hard, and Flatiron has pulled it off.[12]<\/a><\/p>\n

In the future, as healthcare moves toward outcome-based approaches, data-driven precision medicine will increase multi-fold.\u00a0 This represents a strategic opportunity for Roche, and we can expect it to deeply leverage Flatiron\u2019s data and analytics in its digital marketing initiatives, patient assistance programs, and other commercial applications. [13]<\/a><\/p>\n

On the other hand, given the challenges Roche faced while integrating Genentech, it remains to be seen how effective this integration will be.\u00a0 Personally, I sincerely hope Flatiron succeeds because if it does, it will rid the world of Cancer.<\/p>\n

 <\/p>\n

<\/a>References:<\/p>\n

<\/a>[1]<\/a> Flatiron\u2019s Next Phase, Nat Turner, 15 February 2018, Flatiron Blog, https:\/\/flatiron.com\/blog\/roche\/<\/a>, accessed on 9 April 2018<\/p>\n

<\/a>[2]<\/a> At Flatiron Health, doctors and developers work on cracking the code for better cancer treatment, David Zax, April 19 2017, Fast Company, https:\/\/www.fastcompany.com\/3067893\/at-flatiron-health-keeping-the-doctor-close<\/a>, accessed on 9 April 2018<\/p>\n

<\/a>[3]<\/a> Roche acquires Flatiron Health for a cool $1.9B, Catherine Sturman, 12 March 2018, Healthcare Global, http:\/\/www.healthcareglobal.com\/technology\/roche-acquires-flatiron-health-cool-19bn<\/a>, accessed on 9 April 2018<\/p>\n

<\/a>[4]<\/a> The Flatiron Health Acquisition Is A Shot In The Arm For Roche’s Oncology Real-World Evidence Needs, Reenita Das, 26 February 2018, Forbes, https:\/\/www.forbes.com\/sites\/reenitadas\/2018\/02\/26\/flatiron-health-acquisition-a-shot-in-the-arm-for-roches-oncology-real-world-evidence-needs\/#57a0ebbd3f60<\/a>, accessed on 9 April 2018<\/p>\n

<\/a>[5]<\/a> Cost to Develop New Pharmaceutical Drug Now Exceeds $2.5B, Rick Mullin, 24 November 2014, Scientific American, https:\/\/www.scientificamerican.com\/article\/cost-to-develop-new-pharmaceutical-drug-now-exceeds-2-5b\/<\/a>, accessed on 9 April 2018<\/p>\n

<\/a>[6]<\/a> The Flatiron Health Acquisition Is A Shot In The Arm For Roche’s Oncology Real-World Evidence Needs, Reenita Das, 26 February 2018, Forbes, https:\/\/www.forbes.com\/sites\/reenitadas\/2018\/02\/26\/flatiron-health-acquisition-a-shot-in-the-arm-for-roches-oncology-real-world-evidence-needs\/#57a0ebbd3f60<\/a>, accessed on 9 April 2018<\/p>\n

<\/a>[7]<\/a> <\/a>Flatiron\u2019s Next Phase, Nat Turner, 15 February 2018, Flatiron Blog, https:\/\/flatiron.com\/blog\/roche\/<\/a>, accessed on 9 April 2018<\/p>\n

[8]<\/a> Why Drug Giant Roche’s $1.9 Billion Deal to Buy Data Startup Flatiron Health Matters, SY Mukherjee, 16 February 2018, Fortune, http:\/\/fortune.com\/2018\/02\/16\/roche-flatiron-health-deal-why-it-matters\/<\/a>, accessed on 9 April 2018<\/p>\n

<\/a>[9]<\/a> Flatiron Health, AWS case study, https:\/\/aws.amazon.com\/solutions\/case-studies\/flatiron-health\/<\/a>, accessed on 9 April 2018<\/p>\n

<\/a>[10]<\/a> <\/a>Flatiron\u2019s Next Phase, Nat Turner, 15 February 2018, Flatiron Blog, https:\/\/flatiron.com\/blog\/roche\/<\/a>, accessed on 9 April 2018<\/p>\n

[11]<\/a> Roche acquires Flatiron Health for a cool $1.9B, Catherine Sturman, 12 March 2018, Healthcare Global, http:\/\/www.healthcareglobal.com\/technology\/roche-acquires-flatiron-health-cool-19bn<\/a>, accessed on 9 April 2018<\/p>\n

<\/a>[12]<\/a> Why Drug Giant Roche’s $1.9 Billion Deal to Buy Data Startup Flatiron Health Matters, SY Mukherjee, 16 February 2018, Fortune, http:\/\/fortune.com\/2018\/02\/16\/roche-flatiron-health-deal-why-it-matters\/<\/a>, accessed on 9 April 2018<\/p>\n

<\/a>[13]<\/a> The Flatiron Health Acquisition Is A Shot In The Arm For Roche’s Oncology Real-World Evidence Needs, Reenita Das, 26 February 2018, Forbes, https:\/\/www.forbes.com\/sites\/reenitadas\/2018\/02\/26\/flatiron-health-acquisition-a-shot-in-the-arm-for-roches-oncology-real-world-evidence-needs\/#57a0ebbd3f60<\/a>, accessed on 9 April 2018<\/p>\n

Image source: Google images<\/p>\n","protected":false},"excerpt":{"rendered":"

Flatiron Health is using data and analytics to tackle cancer, which it believes cannot be \u201csolved\u201d by just the healthcare community \u2013 it needs the technology industry as well. Therefore, since Flatiron started in 2012, it has grown to nearly […]<\/p>\n","protected":false},"author":2568,"featured_media":8012,"comment_status":"open","ping_status":"closed","template":"","categories":[29,1329,1313,776,2281,2280,24,2279],"class_list":["post-8011","hck-submission","type-hck-submission","status-publish","has-post-thumbnail","hentry","category-big-data","category-cancer-research","category-clinical-trials","category-data-analytics","category-fda","category-flatiron-health","category-healthcare","category-roche","hck-taxonomy-organization-flatiron-health","hck-taxonomy-industry-health","hck-taxonomy-country-united-states"],"connected_submission_link":"https:\/\/d3.harvard.edu\/platform-digit\/assignment\/competing-with-data-challenge\/","yoast_head":"\nFlatiron Health \u2013 solving cancer through data analytics - Digital Innovation and Transformation<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/d3.harvard.edu\/platform-digit\/submission\/flatiron-health-solving-cancer-through-data-analytics\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Flatiron Health \u2013 solving cancer through data analytics - Digital Innovation and Transformation\" \/>\n<meta property=\"og:description\" content=\"Flatiron Health is using data and analytics to tackle cancer, which it believes cannot be \u201csolved\u201d by just the healthcare community \u2013 it needs the technology industry as well. Therefore, since Flatiron started in 2012, it has grown to nearly […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/d3.harvard.edu\/platform-digit\/submission\/flatiron-health-solving-cancer-through-data-analytics\/\" \/>\n<meta property=\"og:site_name\" content=\"Digital Innovation and Transformation\" \/>\n<meta property=\"article:modified_time\" content=\"2018-04-09T21:39:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/d3.harvard.edu\/platform-digit\/wp-content\/uploads\/sites\/2\/2018\/04\/opengraph-logo-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/d3.harvard.edu\\\/platform-digit\\\/submission\\\/flatiron-health-solving-cancer-through-data-analytics\\\/\",\"url\":\"https:\\\/\\\/d3.harvard.edu\\\/platform-digit\\\/submission\\\/flatiron-health-solving-cancer-through-data-analytics\\\/\",\"name\":\"Flatiron Health \u2013 solving cancer through data analytics - Digital Innovation and Transformation\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/d3.harvard.edu\\\/platform-digit\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/d3.harvard.edu\\\/platform-digit\\\/submission\\\/flatiron-health-solving-cancer-through-data-analytics\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/d3.harvard.edu\\\/platform-digit\\\/submission\\\/flatiron-health-solving-cancer-through-data-analytics\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/d3.harvard.edu\\\/platform-digit\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2018\\\/04\\\/opengraph-logo-1.png\",\"datePublished\":\"2018-04-09T21:35:35+00:00\",\"dateModified\":\"2018-04-09T21:39:31+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/d3.harvard.edu\\\/platform-digit\\\/submission\\\/flatiron-health-solving-cancer-through-data-analytics\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/d3.harvard.edu\\\/platform-digit\\\/submission\\\/flatiron-health-solving-cancer-through-data-analytics\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/d3.harvard.edu\\\/platform-digit\\\/submission\\\/flatiron-health-solving-cancer-through-data-analytics\\\/#primaryimage\",\"url\":\"https:\\\/\\\/d3.harvard.edu\\\/platform-digit\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2018\\\/04\\\/opengraph-logo-1.png\",\"contentUrl\":\"https:\\\/\\\/d3.harvard.edu\\\/platform-digit\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2018\\\/04\\\/opengraph-logo-1.png\",\"width\":1200,\"height\":630},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/d3.harvard.edu\\\/platform-digit\\\/submission\\\/flatiron-health-solving-cancer-through-data-analytics\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/d3.harvard.edu\\\/platform-digit\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Submissions\",\"item\":\"https:\\\/\\\/d3.harvard.edu\\\/platform-digit\\\/submission\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Flatiron Health \u2013 solving cancer through data analytics\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/d3.harvard.edu\\\/platform-digit\\\/#website\",\"url\":\"https:\\\/\\\/d3.harvard.edu\\\/platform-digit\\\/\",\"name\":\"Digital Innovation and Transformation\",\"description\":\"MBA Student Perspectives\",\"potentialAction\":[{\"@type\":\"性视界Action\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/d3.harvard.edu\\\/platform-digit\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Flatiron Health \u2013 solving cancer through data analytics - Digital Innovation and Transformation","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/d3.harvard.edu\/platform-digit\/submission\/flatiron-health-solving-cancer-through-data-analytics\/","og_locale":"en_US","og_type":"article","og_title":"Flatiron Health \u2013 solving cancer through data analytics - Digital Innovation and Transformation","og_description":"Flatiron Health is using data and analytics to tackle cancer, which it believes cannot be \u201csolved\u201d by just the healthcare community \u2013 it needs the technology industry as well. Therefore, since Flatiron started in 2012, it has grown to nearly […]","og_url":"https:\/\/d3.harvard.edu\/platform-digit\/submission\/flatiron-health-solving-cancer-through-data-analytics\/","og_site_name":"Digital Innovation and Transformation","article_modified_time":"2018-04-09T21:39:31+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/d3.harvard.edu\/platform-digit\/wp-content\/uploads\/sites\/2\/2018\/04\/opengraph-logo-1.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/d3.harvard.edu\/platform-digit\/submission\/flatiron-health-solving-cancer-through-data-analytics\/","url":"https:\/\/d3.harvard.edu\/platform-digit\/submission\/flatiron-health-solving-cancer-through-data-analytics\/","name":"Flatiron Health \u2013 solving cancer through data analytics - Digital Innovation and Transformation","isPartOf":{"@id":"https:\/\/d3.harvard.edu\/platform-digit\/#website"},"primaryImageOfPage":{"@id":"https:\/\/d3.harvard.edu\/platform-digit\/submission\/flatiron-health-solving-cancer-through-data-analytics\/#primaryimage"},"image":{"@id":"https:\/\/d3.harvard.edu\/platform-digit\/submission\/flatiron-health-solving-cancer-through-data-analytics\/#primaryimage"},"thumbnailUrl":"https:\/\/d3.harvard.edu\/platform-digit\/wp-content\/uploads\/sites\/2\/2018\/04\/opengraph-logo-1.png","datePublished":"2018-04-09T21:35:35+00:00","dateModified":"2018-04-09T21:39:31+00:00","breadcrumb":{"@id":"https:\/\/d3.harvard.edu\/platform-digit\/submission\/flatiron-health-solving-cancer-through-data-analytics\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/d3.harvard.edu\/platform-digit\/submission\/flatiron-health-solving-cancer-through-data-analytics\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/d3.harvard.edu\/platform-digit\/submission\/flatiron-health-solving-cancer-through-data-analytics\/#primaryimage","url":"https:\/\/d3.harvard.edu\/platform-digit\/wp-content\/uploads\/sites\/2\/2018\/04\/opengraph-logo-1.png","contentUrl":"https:\/\/d3.harvard.edu\/platform-digit\/wp-content\/uploads\/sites\/2\/2018\/04\/opengraph-logo-1.png","width":1200,"height":630},{"@type":"BreadcrumbList","@id":"https:\/\/d3.harvard.edu\/platform-digit\/submission\/flatiron-health-solving-cancer-through-data-analytics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/d3.harvard.edu\/platform-digit\/"},{"@type":"ListItem","position":2,"name":"Submissions","item":"https:\/\/d3.harvard.edu\/platform-digit\/submission\/"},{"@type":"ListItem","position":3,"name":"Flatiron Health \u2013 solving cancer through data analytics"}]},{"@type":"WebSite","@id":"https:\/\/d3.harvard.edu\/platform-digit\/#website","url":"https:\/\/d3.harvard.edu\/platform-digit\/","name":"Digital Innovation and Transformation","description":"MBA Student Perspectives","potentialAction":[{"@type":"性视界Action","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/d3.harvard.edu\/platform-digit\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/d3.harvard.edu\/platform-digit\/wp-json\/wp\/v2\/hck-submission\/8011","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/d3.harvard.edu\/platform-digit\/wp-json\/wp\/v2\/hck-submission"}],"about":[{"href":"https:\/\/d3.harvard.edu\/platform-digit\/wp-json\/wp\/v2\/types\/hck-submission"}],"author":[{"embeddable":true,"href":"https:\/\/d3.harvard.edu\/platform-digit\/wp-json\/wp\/v2\/users\/2568"}],"replies":[{"embeddable":true,"href":"https:\/\/d3.harvard.edu\/platform-digit\/wp-json\/wp\/v2\/comments?post=8011"}],"version-history":[{"count":0,"href":"https:\/\/d3.harvard.edu\/platform-digit\/wp-json\/wp\/v2\/hck-submission\/8011\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/d3.harvard.edu\/platform-digit\/wp-json\/wp\/v2\/media\/8012"}],"wp:attachment":[{"href":"https:\/\/d3.harvard.edu\/platform-digit\/wp-json\/wp\/v2\/media?parent=8011"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/d3.harvard.edu\/platform-digit\/wp-json\/wp\/v2\/categories?post=8011"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}